Anavex Life Sciences Corp (AVXL)

[F63]

Anavex is not just a pill against AD.

It will be much more.

For those who compare Anavex with one of the backstreet pill-shops, which exist a lot in the OTC - i say:
Go to the Anavex Homepage and read the data sheets of every single member of the leadership.

http://www.anavex.com/about-us/leadership/

They are building up something much bigger - a basement for a great company with multiple assets in their pipeline already.
It is clearly not their goal to archive one fast success and sell the whole thing to the first bidder.

I will give u an example - here it is regarding the Patents:

Source: http://www.anavex.com/?news=anavex-strengthens-board-of-directors-2

The extract of it:

Anavex Strengthens Board of Directors

NEW YORK, NY – June 18, 2015 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQX: AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS) diseases, pain, and various types of cancer, today announced the appointment of Steffen Thomas, PhD, to its Board of Directors. Dr. Thomas has 15 years of experience in intellectual property, patent law and proprietary technology rights as well as significant expertise in small molecule pharmaceuticals.

Dr. Thomas is currently a patent attorney, European patent attorney and European trademark attorney at Epping Hermann Fischer, a major European intellectual property law firm. Previously, he worked for Japan-based Takeda Pharmaceutical Company, the largest pharmaceutical company in Asia and a top firm worldwide, as an in-house patent attorney. Prior to that, he worked for Nycomed Pharma, which was acquired by Takeda in 2011 for approximately USD $10 billion.

Dr. Thomas’ legal practice covers drafting of patent applications, prosecuting patent applications before national and international patent offices, defending and challenging patents in opposition, appeal, and nullity proceedings, enforcing patents before the infringement courts, and preparing opinions on patentability and infringement in the technical field of chemistry.

“We are pleased to welcome Dr. Thomas to our Board,” said Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex. “We believe Dr. Thomas’ expertise in intellectual property as well as his pharmaceutical industry insight will be extremely beneficial as we are advancing our pipeline.”


What i mean is:

You dont get an Patent-expert onboard if u are going just for 1 single Patent - you will get him when u build up something where u need him again and again - as there is much more than just Anavex 2-73.

One more snippit that fits in the bigger picture comes from this source here:

http://www.anavex.com/?news=anavex-strengthens-alzheimers-pipeline-obtains-exclusive-worldwide-rights-to-intellectual-property

"Obtaining exclusive worldwide rights to this intellectual property is exciting as it is another step in Anavex’s overall strategy to build a broad and leading platform of technology and intellectual property for the development of mixed muscarinic and sigma-1 therapeutics. It also adds to our already dominant position in this field,” said Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex."


Read all the data from the leadership of all members and u see clearly that Anavex has the top of the top of Science and advisors onboard. Here arises a company with high valuable assets and the Ceo really cares about securing the properties.

And also the other members there are very impressive too as:

"Dr. Fisher is co-founding Chairman and President of the Alzheimer’s and Parkinson’s Diseases Conference,is on the scientific review board of the Alzheimer’s Drug Discovery Foundation and is a reviewer of the Alzheimer’s Association."

or

"A member of the Scientific Advisory Board, Dr. Harrison is an internationally acknowledged specialist for design of human clinical outcome measurement in Alzheimer’s disease and other cognitive impairments. Dr. Harrison has successfully integrated cognitive testing into drug development programs for many pharmaceutical and biotechnology companies including eight of the current ‘Fortune’ top 10 pharmaceutical companies."

And so on- there are so much more examples which i could list here.

After studying the leadership i knew, that this is an international top team, which sends a clear signal that they were going for the bigger picture, which gave me much confidence.
The actual listing at the OTC dont really matters me as it it just a question of time when (not if!) the uplisting will be.

So please take the time and do your homework and read all about the company and who runs it - that may answer more questions as to read the pps is up 2 cents or down 3 cents .... and it may also help to differentiate the good from the bad on OTC by doing so - that is called DD.

One last remark for those who are seeking an entry point here in this stock:

An excellent post from Bernadc (tyvm for it) - not much words but sooooo powerful:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=116828225

Thank you for your time reading this and good luck in all your investments.